Effects of a  stepwise, structured LDL-C lowering strategy in patients post-acute coronary syndrome

CONCLUSION: Through stepwise intensification of lipid-lowering therapy, 84% of very high-risk post-ACS patients achieved an LDL‑C target of ≤ 1.8 mmol/l with oral medications alone. Addition of PCSK9i further increased this rate to 87% (95% CI: 85-89).PMID:38277062 | DOI:10.1007/s12471-023-01851-7

Source: Netherlands Heart Journal - January 26, 2024 Category: Cardiology Authors: Aaram Omar Khader Tinka van Trier Sander van der Brug An-Ho Liem Bjorn E Groenemeijer Astrid Schut Harald T Jorstad Fabrice M A C Martens Marco A M W Alings Source Type: research